Table 2.

Summary table of fungal coinfection findings by country (n= total number of patients). [19,79,80,81,82,83,85,88,89,92,94,96,102,103,105,106,110].

Author	Country	Type of Fungal Infection	Severity (ICU, Floor, or Mixed)	Study Type	Total Patients (n)	Fungal Co-Infection (%)	Death (%)
Bartoletti et al.	Italy	Aspergillosis	ICU	Prospective	108	27.7	44
Koehler et al.	Germany	Aspergillosis	ICU	Retrospective	19	26.3	60
White et al.	United Kingdom	Aspergillosis	ICU	Prospective	135	14.1	57.9
Dellière et al.	France	Aspergillosis	ICU	Retrospective	366	5.7	71.4
Lai & Yu	Multiple France Germany Netherlands Belgium Italy Austria	Aspergillosis	Mixed	Review	Total: 34 11 7 7 7 1 1	100	64.7
Musuuza et al.	Multiple	Candidiasis	Mixed	Systematic Review and Meta-analysis	N/A	18.8	N/A
Arastehfar et al.	Multiple Spain India Iran Italy United Kingdom China	Candidiasis	Mixed	Review	989 596 1059 43 135 17	0.3 2.5 5 8 12.6 23.5	66.7 60 N/A N/A 47.1 N/A
Villanueva-Loza no et al.	Mexico	Candidiasis	ICU	Retrospective	12	50	83.3
Coşkun et al.	Turkey	Candidiasis	ICU	Retrospective	627	2.6	80
Antinori et al.	Italy	Candidiasis	Mixed	Prospective	43	6.9	N/A
Seagle et al.	United States	Candidiasis	Mixed	Case-level analysis	64	100	60
Passarelli et al.	United States	Cryptococcosis	ICU	Case report	1	100	100
Khatib et al.	Qatar	Cryptococcosis	ICU	Case report	1	100	100
Ghanem & Sivasubramanian	United States	Cryptococcosis	Mixed	Case Report	1	100	0
Pal et al.	Multiple India United States Egypt Iran Brazil Chile United Kingdom France Italy Austria Mexico	Mucormycosis	Mixed	Systematic review and meta-analysis	Total: 99 71 10 6 3 2 2 1 1 1 1 1	100	34
Jeong et al.	Multiple South America Europe Asia Africa Australia/New Zealand	Mucormycosis	Mixed	Systematic review and Meta-analysis	125 172 111 18 21 Total: 447	14	41